Xeris Pharmaceuticals Inc
XERS
$10.46-0.19%
End of day · as of Oct 12, 2026, 8:15 PM ET
Mkt cap
$760.74M
EV/Sales
2.98
P/E ratio
N/A
FY2025 Revenue
$291.85M
EPS (H1 2026)
$-0.17
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
0.19%
Beta
0.91
Div yield
N/A
Sector
Healthcare
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported XERS revenue for 2025-12-31 was $291.8M. Net income was $554.0K. Revenue was up 43.7% from 2024-12-31 to 2025-12-31. XERS currently screens at market cap $760.7M.
Use this XERS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full XERS income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company in the Healthcare sector.
Latest cached Xeris Pharmaceuticals Inc (XERS) revenue for Dec 31, 2025 was $291.8M. Net income was $554.0K. Statements: https://lician.com/financials/xers
Xeris Pharmaceuticals Inc (XERS) market capitalization is $760.7M on the latest cached snapshot.
Xeris Pharmaceuticals Inc (XERS) cached previous close $10.48; day range $10.46 – $10.47; volume 1,328,410. Session quote: https://lician.com/quote/xers
Xeris Pharmaceuticals Inc (XERS) latest cached earnings event is "XERS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached XERS filing is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/xers